▶ 調査レポート

世界の良性前立腺肥大症治療装置市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Benign Prostatic Hyperplasia Treatment Equipments Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の良性前立腺肥大症治療装置市場規模・現状・予測(2021年-2027年) / Global Benign Prostatic Hyperplasia Treatment Equipments Market Size, Status and Forecast 2021-2027 / QFJ1-5098資料のイメージです。• レポートコード:QFJ1-5098
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、128ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、良性前立腺肥大症治療装置の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(外科治療機器、低侵襲治療機器、レーザー治療機器、その他)、用途別市場規模(病院&診療所、外来手術センター(ASC)、家庭用、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・良性前立腺肥大症治療装置の市場動向
・企業の競争状況、市場シェア
・良性前立腺肥大症治療装置の種類別市場規模と予測2016-2027(外科治療機器、低侵襲治療機器、レーザー治療機器、その他)
・良性前立腺肥大症治療装置の用途別市場規模と予測2016-2027(病院&診療所、外来手術センター(ASC)、家庭用、その他)
・良性前立腺肥大症治療装置の北米市場規模2016-2027(アメリカ、カナダ)
・良性前立腺肥大症治療装置の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・良性前立腺肥大症治療装置のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・良性前立腺肥大症治療装置の中南米市場規模2016-2027(メキシコ、ブラジル)
・良性前立腺肥大症治療装置の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Advin Urology、Biolitec、Boston Scientific Corporation、CONMED、Convergent Laser Technologies、CoreTherm Medical, Inc.、HistoSonics, Inc.、JenaSurgical GmbH、KARL STORZ、LISA Laser Products GmbH、Lumenis Ltd.、Medifocus, Inc、Medtronic plc、Merit Medical Systems, Inc.、NeoTract, Inc.、Olympus Corporation、Pnn Medical AS、PROCEPT BioRobotics、Richard Wolf GmbH、Sophiris Bio, Inc.、Stryker Corporation)
・結論

Market Analysis and Insights: Global Benign Prostatic Hyperplasia Treatment Equipments Market
The global Benign Prostatic Hyperplasia Treatment Equipments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Benign Prostatic Hyperplasia Treatment Equipments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Benign Prostatic Hyperplasia Treatment Equipments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Benign Prostatic Hyperplasia Treatment Equipments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Benign Prostatic Hyperplasia Treatment Equipments market.

Global Benign Prostatic Hyperplasia Treatment Equipments Scope and Market Size
Benign Prostatic Hyperplasia Treatment Equipments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia Treatment Equipments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgical Treatment Equipments
Minimally Invasive Treatment Equipments
Laser Treatment Equipments
Other

Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc.
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc
Medtronic plc
Merit Medical Systems, Inc.
NeoTract, Inc.
Olympus Corporation
Pnn Medical AS
PROCEPT BioRobotics
Richard Wolf GmbH
Sophiris Bio, Inc.
Stryker Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Treatment Equipments
1.2.3 Minimally Invasive Treatment Equipments
1.2.4 Laser Treatment Equipments
1.2.5 Other
1.3 Market by Application
1.3.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Perspective (2016-2027)
2.2 Benign Prostatic Hyperplasia Treatment Equipments Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Treatment Equipments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Benign Prostatic Hyperplasia Treatment Equipments Historic Market Share by Regions (2016-2021)
2.2.3 Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Regions (2022-2027)
2.3 Benign Prostatic Hyperplasia Treatment Equipments Industry Dynamic
2.3.1 Benign Prostatic Hyperplasia Treatment Equipments Market Trends
2.3.2 Benign Prostatic Hyperplasia Treatment Equipments Market Drivers
2.3.3 Benign Prostatic Hyperplasia Treatment Equipments Market Challenges
2.3.4 Benign Prostatic Hyperplasia Treatment Equipments Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Benign Prostatic Hyperplasia Treatment Equipments Players by Revenue
3.1.1 Global Top Benign Prostatic Hyperplasia Treatment Equipments Players by Revenue (2016-2021)
3.1.2 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Players (2016-2021)
3.2 Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Treatment Equipments Revenue
3.4 Global Benign Prostatic Hyperplasia Treatment Equipments Market Concentration Ratio
3.4.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Treatment Equipments Revenue in 2020
3.5 Benign Prostatic Hyperplasia Treatment Equipments Key Players Head office and Area Served
3.6 Key Players Benign Prostatic Hyperplasia Treatment Equipments Product Solution and Service
3.7 Date of Enter into Benign Prostatic Hyperplasia Treatment Equipments Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Benign Prostatic Hyperplasia Treatment Equipments Breakdown Data by Type
4.1 Global Benign Prostatic Hyperplasia Treatment Equipments Historic Market Size by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Type (2022-2027)

5 Benign Prostatic Hyperplasia Treatment Equipments Breakdown Data by Application
5.1 Global Benign Prostatic Hyperplasia Treatment Equipments Historic Market Size by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size (2016-2027)
6.2 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type
6.2.1 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021)
6.2.2 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027)
6.2.3 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2027)
6.3 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application
6.3.1 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021)
6.3.2 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027)
6.3.3 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2027)
6.4 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country
6.4.1 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021)
6.4.2 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size (2016-2027)
7.2 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type
7.2.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021)
7.2.2 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027)
7.2.3 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2027)
7.3 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application
7.3.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021)
7.3.2 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027)
7.3.3 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2027)
7.4 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country
7.4.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021)
7.4.2 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size (2016-2027)
8.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type
8.2.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2027)
8.3 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application
8.3.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2027)
8.4 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region
8.4.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size (2016-2027)
9.2 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type
9.2.1 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021)
9.2.2 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027)
9.2.3 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2027)
9.3 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application
9.3.1 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021)
9.3.2 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027)
9.3.3 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2027)
9.4 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country
9.4.1 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021)
9.4.2 Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size (2016-2027)
10.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type
10.2.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2027)
10.3 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application
10.3.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2027)
10.4 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country
10.4.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Advin Urology
11.1.1 Advin Urology Company Details
11.1.2 Advin Urology Business Overview
11.1.3 Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.1.4 Advin Urology Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.1.5 Advin Urology Recent Development
11.2 Biolitec
11.2.1 Biolitec Company Details
11.2.2 Biolitec Business Overview
11.2.3 Biolitec Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.2.4 Biolitec Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.2.5 Biolitec Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Details
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.3.4 Boston Scientific Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.3.5 Boston Scientific Corporation Recent Development
11.4 CONMED
11.4.1 CONMED Company Details
11.4.2 CONMED Business Overview
11.4.3 CONMED Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.4.4 CONMED Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.4.5 CONMED Recent Development
11.5 Convergent Laser Technologies
11.5.1 Convergent Laser Technologies Company Details
11.5.2 Convergent Laser Technologies Business Overview
11.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.5.4 Convergent Laser Technologies Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.5.5 Convergent Laser Technologies Recent Development
11.6 CoreTherm Medical, Inc.
11.6.1 CoreTherm Medical, Inc. Company Details
11.6.2 CoreTherm Medical, Inc. Business Overview
11.6.3 CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.6.4 CoreTherm Medical, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.6.5 CoreTherm Medical, Inc. Recent Development
11.7 HistoSonics, Inc.
11.7.1 HistoSonics, Inc. Company Details
11.7.2 HistoSonics, Inc. Business Overview
11.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.7.4 HistoSonics, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.7.5 HistoSonics, Inc. Recent Development
11.8 JenaSurgical GmbH
11.8.1 JenaSurgical GmbH Company Details
11.8.2 JenaSurgical GmbH Business Overview
11.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.8.4 JenaSurgical GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.8.5 JenaSurgical GmbH Recent Development
11.9 KARL STORZ
11.9.1 KARL STORZ Company Details
11.9.2 KARL STORZ Business Overview
11.9.3 KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.9.4 KARL STORZ Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.9.5 KARL STORZ Recent Development
11.10 LISA Laser Products GmbH
11.10.1 LISA Laser Products GmbH Company Details
11.10.2 LISA Laser Products GmbH Business Overview
11.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.10.4 LISA Laser Products GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.10.5 LISA Laser Products GmbH Recent Development
11.11 Lumenis Ltd.
11.11.1 Lumenis Ltd. Company Details
11.11.2 Lumenis Ltd. Business Overview
11.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.11.4 Lumenis Ltd. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.11.5 Lumenis Ltd. Recent Development
11.12 Medifocus, Inc
11.12.1 Medifocus, Inc Company Details
11.12.2 Medifocus, Inc Business Overview
11.12.3 Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.12.4 Medifocus, Inc Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.12.5 Medifocus, Inc Recent Development
11.13 Medtronic plc
11.13.1 Medtronic plc Company Details
11.13.2 Medtronic plc Business Overview
11.13.3 Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.13.4 Medtronic plc Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.13.5 Medtronic plc Recent Development
11.14 Merit Medical Systems, Inc.
11.14.1 Merit Medical Systems, Inc. Company Details
11.14.2 Merit Medical Systems, Inc. Business Overview
11.14.3 Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.14.4 Merit Medical Systems, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.14.5 Merit Medical Systems, Inc. Recent Development
11.15 NeoTract, Inc.
11.15.1 NeoTract, Inc. Company Details
11.15.2 NeoTract, Inc. Business Overview
11.15.3 NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.15.4 NeoTract, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.15.5 NeoTract, Inc. Recent Development
11.16 Olympus Corporation
11.16.1 Olympus Corporation Company Details
11.16.2 Olympus Corporation Business Overview
11.16.3 Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.16.4 Olympus Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.16.5 Olympus Corporation Recent Development
11.17 Pnn Medical AS
11.17.1 Pnn Medical AS Company Details
11.17.2 Pnn Medical AS Business Overview
11.17.3 Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.17.4 Pnn Medical AS Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.17.5 Pnn Medical AS Recent Development
11.18 PROCEPT BioRobotics
11.18.1 PROCEPT BioRobotics Company Details
11.18.2 PROCEPT BioRobotics Business Overview
11.18.3 PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.18.4 PROCEPT BioRobotics Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.18.5 PROCEPT BioRobotics Recent Development
11.18 Richard Wolf GmbH
.1 Richard Wolf GmbH Company Details
.2 Richard Wolf GmbH Business Overview
.3 Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Introduction
.4 Richard Wolf GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
.5 Richard Wolf GmbH Recent Development
11.20 Sophiris Bio, Inc.
11.20.1 Sophiris Bio, Inc. Company Details
11.20.2 Sophiris Bio, Inc. Business Overview
11.20.3 Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.20.4 Sophiris Bio, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.20.5 Sophiris Bio, Inc. Recent Development
11.21 Stryker Corporation
11.21.1 Stryker Corporation Company Details
11.21.2 Stryker Corporation Business Overview
11.21.3 Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Introduction
11.21.4 Stryker Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
11.21.5 Stryker Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Treatment Equipments
Table 3. Key Players of Minimally Invasive Treatment Equipments
Table 4. Key Players of Laser Treatment Equipments
Table 5. Key Players of Other
Table 6. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Regions (2016-2021)
Table 10. Global Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Regions (2022-2027)
Table 12. Benign Prostatic Hyperplasia Treatment Equipments Market Trends
Table 13. Benign Prostatic Hyperplasia Treatment Equipments Market Drivers
Table 14. Benign Prostatic Hyperplasia Treatment Equipments Market Challenges
Table 15. Benign Prostatic Hyperplasia Treatment Equipments Market Restraints
Table 16. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Players (2016-2021)
Table 18. Global Top Benign Prostatic Hyperplasia Treatment Equipments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Treatment Equipments as of 2020)
Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Treatment Equipments Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Treatment Equipments Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Benign Prostatic Hyperplasia Treatment Equipments Product Solution and Service
Table 23. Date of Enter into Benign Prostatic Hyperplasia Treatment Equipments Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type (2016-2021)
Table 27. Global Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application (2016-2021)
Table 31. Global Benign Prostatic Hyperplasia Treatment Equipments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country (2022-2027) & (US$ Million)
Table 63. Advin Urology Company Details
Table 64. Advin Urology Business Overview
Table 65. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Product
Table 66. Advin Urology Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 67. Advin Urology Recent Development
Table 68. Biolitec Company Details
Table 69. Biolitec Business Overview
Table 70. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Product
Table 71. Biolitec Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 72. Biolitec Recent Development
Table 73. Boston Scientific Corporation Company Details
Table 74. Boston Scientific Corporation Business Overview
Table 75. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Product
Table 76. Boston Scientific Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 77. Boston Scientific Corporation Recent Development
Table 78. CONMED Company Details
Table 79. CONMED Business Overview
Table 80. CONMED Benign Prostatic Hyperplasia Treatment Equipments Product
Table 81. CONMED Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 82. CONMED Recent Development
Table 83. Convergent Laser Technologies Company Details
Table 84. Convergent Laser Technologies Business Overview
Table 85. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Product
Table 86. Convergent Laser Technologies Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 87. Convergent Laser Technologies Recent Development
Table 88. CoreTherm Medical, Inc. Company Details
Table 89. CoreTherm Medical, Inc. Business Overview
Table 90. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 91. CoreTherm Medical, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 92. CoreTherm Medical, Inc. Recent Development
Table 93. HistoSonics, Inc. Company Details
Table 94. HistoSonics, Inc. Business Overview
Table 95. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 96. HistoSonics, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 97. HistoSonics, Inc. Recent Development
Table 98. JenaSurgical GmbH Company Details
Table 99. JenaSurgical GmbH Business Overview
Table 100. JenaSurgical GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 101. JenaSurgical GmbH Recent Development
Table 102. KARL STORZ Company Details
Table 103. KARL STORZ Business Overview
Table 104. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Product
Table 105. KARL STORZ Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 106. KARL STORZ Recent Development
Table 107. LISA Laser Products GmbH Company Details
Table 108. LISA Laser Products GmbH Business Overview
Table 109. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Product
Table 110. LISA Laser Products GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 111. LISA Laser Products GmbH Recent Development
Table 112. Lumenis Ltd. Company Details
Table 113. Lumenis Ltd. Business Overview
Table 114. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 115. Lumenis Ltd. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 116. Lumenis Ltd. Recent Development
Table 117. Medifocus, Inc Company Details
Table 118. Medifocus, Inc Business Overview
Table 119. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Product
Table 120. Medifocus, Inc Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 121. Medifocus, Inc Recent Development
Table 122. Medtronic plc Company Details
Table 123. Medtronic plc Business Overview
Table 124. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Product
Table 125. Medtronic plc Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 126. Medtronic plc Recent Development
Table 127. Merit Medical Systems, Inc. Company Details
Table 128. Merit Medical Systems, Inc. Business Overview
Table 129. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 130. Merit Medical Systems, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 131. Merit Medical Systems, Inc. Recent Development
Table 132. NeoTract, Inc. Company Details
Table 133. NeoTract, Inc. Business Overview
Table 134. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 135. NeoTract, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 136. NeoTract, Inc. Recent Development
Table 137. Olympus Corporation Company Details
Table 138. Olympus Corporation Business Overview
Table 139. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Product
Table 140. Olympus Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 141. Olympus Corporation Recent Development
Table 142. Pnn Medical AS Company Details
Table 143. Pnn Medical AS Business Overview
Table 144. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Product
Table 145. Pnn Medical AS Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 146. Pnn Medical AS Recent Development
Table 147. PROCEPT BioRobotics Company Details
Table 148. PROCEPT BioRobotics Business Overview
Table 149. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Product
Table 150. PROCEPT BioRobotics Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 151. PROCEPT BioRobotics Recent Development
Table 152. Richard Wolf GmbH Company Details
Table 153. Richard Wolf GmbH Business Overview
Table 154. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Product
Table 155. Richard Wolf GmbH Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 156. Richard Wolf GmbH Recent Development
Table 157. Sophiris Bio, Inc. Company Details
Table 158. Sophiris Bio, Inc. Business Overview
Table 159. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product
Table 160. Sophiris Bio, Inc. Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 161. Sophiris Bio, Inc. Recent Development
Table 162. Stryker Corporation Company Details
Table 163. Stryker Corporation Business Overview
Table 164. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Product
Table 165. Stryker Corporation Revenue in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021) & (US$ Million)
Table 166. Stryker Corporation Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type: 2020 VS 2027
Figure 2. Surgical Treatment Equipments Features
Figure 3. Minimally Invasive Treatment Equipments Features
Figure 4. Laser Treatment Equipments Features
Figure 5. Other Features
Figure 6. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application: 2020 VS 2027
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Ambulatory Surgical Centers(ASC) Case Studies
Figure 9. Home Case Studies
Figure 10. Others Case Studies
Figure 11. Benign Prostatic Hyperplasia Treatment Equipments Report Years Considered
Figure 12. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Regions: 2020 VS 2027
Figure 15. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Regions (2022-2027)
Figure 16. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share by Players in 2020
Figure 17. Global Top Benign Prostatic Hyperplasia Treatment Equipments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Treatment Equipments as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Treatment Equipments Revenue in 2020
Figure 19. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type (2016-2021)
Figure 20. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type (2022-2027)
Figure 21. North America Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type (2016-2027)
Figure 23. North America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application (2016-2027)
Figure 24. North America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Country (2016-2027)
Figure 25. United States Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type (2016-2027)
Figure 29. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application (2016-2027)
Figure 30. Europe Benign Prostatic Hyperplasia Treatment Equipments Market Share by Country (2016-2027)
Figure 31. Germany Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Share by Region (2016-2027)
Figure 41. China Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type (2016-2027)
Figure 49. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application (2016-2027)
Figure 50. Latin America Benign Prostatic Hyperplasia Treatment Equipments Market Share by Country (2016-2027)
Figure 51. Mexico Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Share by Country (2016-2027)
Figure 57. Turkey Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Benign Prostatic Hyperplasia Treatment Equipments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Advin Urology Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 61. Biolitec Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 62. Boston Scientific Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 63. CONMED Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 64. Convergent Laser Technologies Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 65. CoreTherm Medical, Inc. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 66. HistoSonics, Inc. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 67. JenaSurgical GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 68. KARL STORZ Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 69. LISA Laser Products GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 70. Lumenis Ltd. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 71. Medifocus, Inc Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 72. Medtronic plc Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 73. Merit Medical Systems, Inc. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 74. NeoTract, Inc. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 75. Olympus Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 76. Pnn Medical AS Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 77. PROCEPT BioRobotics Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 78. Richard Wolf GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 79. Sophiris Bio, Inc. Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 80. Stryker Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Equipments Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed